← Leaderboards
Hui-Kuo Shu
Emory University
$1,642,136
Attributed
$5,187,159
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–19$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,187,159 · 4
By mechanism
U01$3,171,477 · 1
RC1$850,335 · 1
R01$739,097 · 1
R21$426,250 · 1
Top collaborators
- Hyunsuk Shim11 shared
- Peter B Barker5 shared
- Xiaoping P Hu5 shared
- Jeffrey J Olson5 shared
Most similar at Emory University
Same institution · by research overlap
- Hyunsuk Shim$7,356,562
- Clinton H. Joiner$9,117,959
- Jeffrey J Olson$1,258,074
- Xiaofeng Yang$4,796,965
- Michael J Owens$5,654,463
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsTumorInhibitor/AntagonistBaseResponsePharmaceutical PreparationsOperative Surgical ProceduresPre-ClinicalResolutionPrimary Brain NeoplasmsNewly DiagnosedNeurocognitionMapsQuality Of LifeGliomaGlioblastomaInstitutionImageBrainMagnetic Resonance ImagingBiopsyMagnetic Resonance Spectroscopic ImagingN-AcetylaspartateMetabolic
Grant awards (11)
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients$138,906
R01 · FY2019 · CA
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients$287,297
R01 · FY2018 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management$617,130
U01 · FY2017 · CA
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients$312,894
R01 · FY2017 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management$623,858
U01 · FY2016 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management$632,744
U01 · FY2015 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management$626,579
U01 · FY2014 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management$671,166
U01 · FY2013 · CA
Blockade of the SDF-1/CXCR4 axis as a novel strategy for mitigating radiation-ind$850,335
RC1 · FY2010 · AI · contact PI
Inhibition of the SDF-1/CXCR4 axis as preventive therapy for radiation-induced pu$232,500
R21 · FY2010 · HL · contact PI
Inhibition of the SDF-1/CXCR4 axis as preventive therapy for radiation-induced pu$193,750
R21 · FY2009 · HL · contact PI